Literature DB >> 24200922

Tissue-type plasminogen activator mediates neuroglial coupling in the central nervous system.

J An1, W B Haile2, F Wu2, E Torre2, M Yepes3.   

Abstract

The interaction between neurons, astrocytes and endothelial cells plays a central role coupling energy supply with changes in neuronal activity. For a long time it was believed that glucose was the only source of energy for neurons. However, a growing body of experimental evidence indicates that lactic acid, generated by aerobic glycolysis in perivascular astrocytes, is also a source of energy for neuronal activity, particularly when the supply of glucose from the intravascular space is interrupted. Adenosine monophosphate-activated protein kinase (AMPK) is an evolutionary conserved kinase that couples cellular activity with energy consumption via induction of the uptake of glucose and activation of the glycolytic pathway. The uptake of glucose by the blood-brain barrier is mediated by glucose transporter-1 (GLUT1), which is abundantly expressed in endothelial cells and astrocytic end-feet processes. Tissue-type plasminogen activator (tPA) is a serine proteinase that is found in endothelial cells, astrocytes and neurons. Genetic overexpression of neuronal tPA or treatment with recombinant tPA protects neurons from the deleterious effects of metabolic stress or excitotoxicity, via a mechanism independent of tPA's ability to cleave plasminogen into plasmin. The work presented here shows that exposure to metabolic stress induces the rapid release of tPA from murine neurons but not from astrocytes. This tPA induces AMPK activation, membrane recruitment of GLUT1, and GLUT1-mediated glucose uptake in astrocytes and endothelial cells. Our data indicate that this is followed by the synthesis and release of lactic acid from astrocytes, and that the uptake of this lactic acid via the monocarboxylate transporter-2 promotes survival in neurons exposed to metabolic stress. Published by Elsevier Ltd.

Entities:  

Keywords:  1,4-dideoxy-1,4-imino-d-arabinitol hydrochloride; 2-N (7-nitrobenz-2-oxa-1,3-diazol-4-yl-amino)-2-deoxyglucose; 2-NBDG; 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide; 4′-6-diamidino-2-phenylindole; AMPK; BBB; BCA; DAPI; DH; ELISA; GFAP; GLUT1; HEPES; MCT-2; MTT; N-(2-hydroxyethyl)piperazine-N′-2-ethanesulfonic acid; OGD; RBMVEC; adenosine monophosphate-activated protein kinase; adenosine monophosphate-activated protein kinase (AMPK); bicinchoninic acid; blood–brain barrier; enzyme-linked immunosorbent assay; glial fibrillary acidic protein; glucose metabolism; glucose transporter-1; monocarboxylate transporter-2; monocarboxylate transporter-2 (MCT-2); neuroprotection; oxygen and glucose deprivation; rat brain microvascular endothelial cells; tPA; tissue-type plasminogen activator; tissue-type plasminogen activator (tPA)

Mesh:

Substances:

Year:  2013        PMID: 24200922      PMCID: PMC3889071          DOI: 10.1016/j.neuroscience.2013.10.060

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  25 in total

1.  Nomenclature of the GLUT/SLC2A family of sugar/polyol transport facilitators.

Authors:  Hans-Georg Joost; Graeme I Bell; James D Best; Morris J Birnbaum; Maureen J Charron; Y T Chen; Holger Doege; David E James; Harvey F Lodish; Kelle H Moley; Jeffrey F Moley; Mike Mueckler; Suzanne Rogers; Annette Schürmann; Susumu Seino; Bernard Thorens
Journal:  Am J Physiol Endocrinol Metab       Date:  2002-04       Impact factor: 4.310

2.  MCT2 is a major neuronal monocarboxylate transporter in the adult mouse brain.

Authors:  Karin Pierre; Pierre J Magistretti; Luc Pellerin
Journal:  J Cereb Blood Flow Metab       Date:  2002-05       Impact factor: 6.200

Review 3.  An energy budget for signaling in the grey matter of the brain.

Authors:  D Attwell; S B Laughlin
Journal:  J Cereb Blood Flow Metab       Date:  2001-10       Impact factor: 6.200

4.  Food for thought: challenging the dogmas.

Authors:  Luc Pellerin; Pierre J Magistretti
Journal:  J Cereb Blood Flow Metab       Date:  2003-11       Impact factor: 6.200

5.  Cloning and characterization of a cDNA encoding the rat brain glucose-transporter protein.

Authors:  M J Birnbaum; H C Haspel; O M Rosen
Journal:  Proc Natl Acad Sci U S A       Date:  1986-08       Impact factor: 11.205

Review 6.  The extended GLUT-family of sugar/polyol transport facilitators: nomenclature, sequence characteristics, and potential function of its novel members (review).

Authors:  H G Joost; B Thorens
Journal:  Mol Membr Biol       Date:  2001 Oct-Dec       Impact factor: 2.857

7.  Glutamate mediates acute glucose transport inhibition in hippocampal neurons.

Authors:  Omar H Porras; Anitsi Loaiza; L Felipe Barros
Journal:  J Neurosci       Date:  2004-10-27       Impact factor: 6.167

8.  Tissue-type plasminogen activator protects neurons from excitotoxin-induced cell death via activation of the ERK1/2-CREB-ATF3 signaling pathway.

Authors:  Fang Wu; Ramiro Echeverry; Jialing Wu; Jie An; Woldeab B Haile; Deborah S Cooper; Marcela Catano; Manuel Yepes
Journal:  Mol Cell Neurosci       Date:  2012-10-09       Impact factor: 4.314

Review 9.  Lactate metabolism: a new paradigm for the third millennium.

Authors:  L B Gladden
Journal:  J Physiol       Date:  2004-05-06       Impact factor: 5.182

10.  Tissue-type plasminogen activator induces opening of the blood-brain barrier via the LDL receptor-related protein.

Authors:  Manuel Yepes; Maria Sandkvist; Elizabeth G Moore; Thomas H Bugge; Dudley K Strickland; Daniel A Lawrence
Journal:  J Clin Invest       Date:  2003-11       Impact factor: 14.808

View more
  19 in total

1.  Time-Dependent Lactate Production and Amino Acid Utilization in Cultured Astrocytes Under High Glucose Exposure.

Authors:  Dan Wang; Liangcai Zhao; Hong Zheng; Minjian Dong; Linlin Pan; Xi Zhang; Huajie Zhang; Hongchang Gao
Journal:  Mol Neurobiol       Date:  2017-01-16       Impact factor: 5.590

2.  Tissue-type plasminogen activator triggers the synaptic vesicle cycle in cerebral cortical neurons.

Authors:  Fang Wu; Enrique Torre; David Cuellar-Giraldo; Lihong Cheng; Hong Yi; Edyta K Bichler; Paul S García; Manuel Yepes
Journal:  J Cereb Blood Flow Metab       Date:  2015-07-01       Impact factor: 6.200

Review 3.  New insights into targeting mitochondria in ischemic injury.

Authors:  Jingjing Jia; Haiqiang Jin; Ding Nan; Weiwei Yu; Yining Huang
Journal:  Apoptosis       Date:  2021-03-09       Impact factor: 4.677

4.  Does treatment with t-PA increase the risk of developing epilepsy after stroke?

Authors:  Lena Keller; Carsten Hobohm; Samira Zeynalova; Joseph Classen; Petra Baum
Journal:  J Neurol       Date:  2015-07-24       Impact factor: 4.849

5.  Tissue-type plasminogen activator regulates p35-mediated Cdk5 activation in the postsynaptic terminal.

Authors:  Ariel Diaz; Valerie Jeanneret; Paola Merino; Patrick McCann; Manuel Yepes
Journal:  J Cell Sci       Date:  2019-02-28       Impact factor: 5.285

Review 6.  Advances in astrocyte-targeted approaches for stroke therapy: an emerging role for mitochondria and microRNAS.

Authors:  Creed M Stary; Rona G Giffard
Journal:  Neurochem Res       Date:  2014-07-04       Impact factor: 3.996

Review 7.  tPA Modulation of the Blood-Brain Barrier: A Unifying Explanation for the Pleiotropic Effects of tPA in the CNS.

Authors:  Linda Fredriksson; Daniel A Lawrence; Robert L Medcalf
Journal:  Semin Thromb Hemost       Date:  2016-09-27       Impact factor: 4.180

8.  The Plasminogen Activation System Promotes Dendritic Spine Recovery and Improvement in Neurological Function After an Ischemic Stroke.

Authors:  Valerie Jeanneret; Manuel Yepes
Journal:  Transl Stroke Res       Date:  2016-02-04       Impact factor: 6.829

9.  Tissue-type plasminogen activator induces synaptic vesicle endocytosis in cerebral cortical neurons.

Authors:  M Yepes; F Wu; E Torre; D Cuellar-Giraldo; D Jia; L Cheng
Journal:  Neuroscience       Date:  2016-01-26       Impact factor: 3.590

Review 10.  Glucose transporters in brain in health and disease.

Authors:  Hermann Koepsell
Journal:  Pflugers Arch       Date:  2020-08-13       Impact factor: 3.657

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.